PureTech Health (PRTC) News Today GBX 138.40 -1.20 (-0.86%) As of 11:46 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period PureTech announces receipt of FDA Fast Track Designation for LYT-200 in AMLJanuary 10, 2025 | finance.yahoo.comPureTech Health (LON:PRTC) Sets New 52-Week Low - Here's WhyPureTech Health (LON:PRTC) Hits New 1-Year Low - Should You Sell?January 9, 2025 | marketbeat.comPureTech Health (LON:PRTC) Given "Buy" Rating at Jefferies Financial GroupJefferies Financial Group reiterated a "buy" rating and issued a GBX 455 ($5.74) target price on shares of PureTech Health in a research report on Monday.December 16, 2024 | marketbeat.comPureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024December 11, 2024 | finance.yahoo.comPureTech Health (LON:PRTC) Shares Up 1.1% - Here's What HappenedPureTech Health (LON:PRTC) Trading 1.1% Higher - What's Next?December 5, 2024 | marketbeat.comPositive Outlook on PureTech Health’s LYT-100 Amid Potential Breakthrough in IPF TreatmentNovember 22, 2024 | markets.businessinsider.comPureTech Health (LON:PRTC) Share Price Passes Above 50 Day Moving Average - Here's WhyPureTech Health (LON:PRTC) Stock Passes Above 50 Day Moving Average - Time to Sell?October 26, 2024 | marketbeat.comPureTech Health (LON:PRTC) Share Price Crosses Above 50-Day Moving Average - Here's What HappenedPureTech Health (LON:PRTC) Stock Price Crosses Above 50 Day Moving Average - Time to Sell?October 18, 2024 | marketbeat.comPureTech Health (LON:PRTC) Stock Price Passes Below 50-Day Moving Average - Should You Sell?PureTech Health (LON:PRTC) Shares Pass Below 50-Day Moving Average - Here's What HappenedOctober 10, 2024 | marketbeat.comPureTech Health (LON:PRTC) Hits New 12-Month Low at $138.75PureTech Health (LON:PRTC) Hits New 12-Month Low at $138.75October 2, 2024 | marketbeat.comFDA approves PureTech’s KarXT to treat schizophrenia in adultsSeptember 30, 2024 | finance.yahoo.comAfter hitting a five-year low I’m betting this hidden gem will rocket like the Rolls-Royce share priceSeptember 25, 2024 | fool.co.ukPureTech Health (LON:PRTC) Share Price Crosses Below 50 Day Moving Average of $162.62PureTech Health (LON:PRTC) Stock Crosses Below Fifty Day Moving Average of $162.62September 25, 2024 | marketbeat.comPureTech Health (LON:PRTC) Share Price Crosses Below 50-Day Moving Average of $166.97PureTech Health (LON:PRTC) Shares Cross Below 50-Day Moving Average of $166.97September 17, 2024 | marketbeat.comAnalyst starts PureTech Health coverage with Outperform, notes potential in deuterated moleculesSeptember 11, 2024 | investing.comPureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted TherapiesSeptember 6, 2024 | finance.yahoo.comOptimistic Outlook for PureTech Health: Strong Pipeline and Financial Strategy Justify Buy RatingAugust 30, 2024 | markets.businessinsider.comPureTech Health plc (NASDAQ:PRTC) Q2 2024 Earnings Call TranscriptAugust 29, 2024 | msn.comPureTech Health plc (PRTC) Q2 2024 Earnings Call TranscriptAugust 28, 2024 | seekingalpha.comPureTech Health (LON:PRTC) Shares Pass Below Fifty Day Moving Average of $205.27PureTech Health (LON:PRTC) Stock Passes Below 50-Day Moving Average of $205.27July 24, 2024 | marketbeat.comRobert Langer Sells 233,098 Shares of PureTech Health plc (LON:PRTC) StockJune 29, 2024 | insidertrades.comPureTech Health plc (LON:PRTC) Insider Sells £582,745 in StockPureTech Health plc (LON:PRTC - Get Free Report) insider Robert Langer sold 233,098 shares of PureTech Health stock in a transaction dated Monday, June 24th. The shares were sold at an average price of GBX 250 ($3.17), for a total value of £582,745 ($739,242.67).June 27, 2024 | marketbeat.comPureTech Names Bharatt Chowrira CEO As Daphne Zohar Turns CEO Of Newly Launched Seaport TherapeuticsApril 9, 2024 | markets.businessinsider.comHere’s one FTSE 250 stock I’d buy in AprilApril 2, 2024 | msn.comPureTech Health plcMarch 22, 2024 | thestreet.comPureTech announces $100M capital return through tender offerMarch 19, 2024 | msn.comAKLI Mar 2024 1.000 callFebruary 28, 2024 | finance.yahoo.com2 impressive growth stocks I’ve got my eye on in FebruaryFebruary 8, 2024 | msn.comPureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in SchizophreniaNovember 17, 2023 | finance.yahoo.comPureTech Health celebrates positive results in Phase 2 anxiety trialNovember 14, 2023 | lse.co.ukPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy VolunteersNovember 14, 2023 | finance.yahoo.comPureTech Health plc - Half-Year ReportAugust 29, 2023 | finanznachrichten.dePureTech bags $11.4M from U.S. Department of Defense contractAugust 1, 2023 | msn.comPureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia SyndromeAugust 1, 2023 | finance.yahoo.comPureTech Health launches next stage of anxiety disorder drug trialJune 21, 2023 | lse.co.ukPureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety DisordersJune 21, 2023 | finance.yahoo.comPureTech Health Stock (NASDAQ:PRTC), DividendsApril 29, 2023 | benzinga.comPureTech Health FY22 Revenue Declines 10.2% YoY, Here Are The DetailsApril 28, 2023 | markets.businessinsider.comMicrobiome-focused PureTech spinout raises $106.5M to fund two trialsApril 25, 2023 | bizjournals.comPureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia TherapiesApril 25, 2023 | finance.yahoo.comPureTech Health's Vedanta Biosciences boasts "promising" resultsApril 20, 2023 | lse.co.ukPureTech Health remains undervalued after KarXCT deal, says brokerMarch 23, 2023 | proactiveinvestors.comPureTech Health Shares Rise on Schizophrenia Treatment Candidate Royalty DealMarch 23, 2023 | marketwatch.comRoyalty Pharma Acquires Interest In PureTech's Royalty In Karuna Therapeutics' KarXTMarch 23, 2023 | markets.businessinsider.comPureTech Health shares jump 10% on US$500mln royalty dealMarch 23, 2023 | proactiveinvestors.comRoyalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 MillionMarch 23, 2023 | finance.yahoo.comPureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)February 27, 2023 | finance.yahoo.comPureTech Health's Depression Treatment Phase 1 Study Shows Positive DataDecember 19, 2022 | marketwatch.comPureTech to Present at 41st Annual J.P. Morgan Healthcare ConferenceDecember 13, 2022 | finance.yahoo.comPureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual MeetingDecember 12, 2022 | finance.yahoo.com Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address PRTC Media Mentions By Week PRTC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTC News Sentiment▼0.000.60▲Average Medical News Sentiment PRTC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTC Articles This Week▼00▲PRTC Articles Average Week Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GNS News Today OXB News Today FARN News Today AVCT News Today BVXP News Today 4BB News Today HVO News Today FUM News Today SCLP News Today REDX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:PRTC) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
